Language Select
Moataz Karmalawy, PhD
Vice President and General Manager, Worldwide Particle Therapy

Moataz Karmalawy, PhD, is the Vice President and General Manager world wide of Varian's Particle Therapy business, which developed the ProBeam® proton therapy system, integrating scanning beam intensity-modulated proton therapy (IMPT) with advanced technologies for image-guidance and patient positioning. He joined the company in 2007.

Prior to joining Varian, Dr. Karmalawy held a variety of management positions with Philips Medical Systems, including Vice President for Research and Development, Vice President of Operations, and Vice President of strategic Research and Development. Prior to that, he spent five years directing Nuclear Medicine Systems Operations at Park Medical Systems in Canada. Dr. Karmalawy has directed successful product launches in the Cardiology and General Nuclear Medicine market segments, including PET, SPECT, PET-CT, and diagnostic SPECT/CT imaging. Dr. Karmalawy holds a M.A.Sc and a PhD in Engineering, as well as an MBA from Concordia University and McGill University in Montreal, Canada. He also holds a number of patents and has published in major technical journals.